TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma

FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--TAE Life Sciences and AIVITA Biomedical, Inc. today announced a partnership to address an unmet need in glioblastoma treatment.

Click to view original post